Research shows that vitamin B12 supplementation significantly protected mice from colitis caused by AIEC bacteria, preventing weight loss and tissue damage even when infected with harmful bacteria. According to Gram Research analysis, this 2026 study found that vitamin B12 works by blocking the bacteria’s ability to invade intestinal cells through a specific gene called pduB. These findings suggest vitamin B12 availability may be a new therapeutic target for treating AIEC-driven Crohn’s disease, though human studies are needed to confirm effectiveness in people.
Researchers discovered that a specific type of harmful bacteria called AIEC, which is linked to Crohn’s disease, uses a special gene called pduB to invade the intestines and cause inflammation. According to Gram Research analysis, when scientists removed this gene or gave mice extra vitamin B12, the bacteria couldn’t invade as easily and the mice stayed healthier. This finding suggests that vitamin B12 levels might be a new way to fight this type of gut bacteria and could lead to new treatments for people with inflammatory bowel disease.
Key Statistics
A 2026 research article published in mBio found that vitamin B12 supplementation protected mice from AIEC-induced colitis by preventing weight loss, rectal prolapse, and tissue damage, even in animals colonized with wild-type bacteria.
Deletion of the pduB gene in AIEC bacteria impaired the bacteria’s ability to invade intestinal epithelial cells without affecting bacterial growth or biofilm formation, demonstrating that this specific gene is critical for bacterial invasion.
Vitamin B12-mediated protection against AIEC colitis was dependent on an intact pdu pathway, indicating that the bacteria must be able to use vitamin B12 for the vitamin to provide protective effects against infection.
Mice infected with pduB-deficient AIEC showed significantly reduced expression of pro-inflammatory cytokines including IL-6, IL-1 beta, and TNF-alpha, indicating substantially lower intestinal inflammation compared to mice infected with normal bacteria.
The Quick Take
- What they studied: Whether a specific bacterial gene and vitamin B12 levels affect how much damage a harmful gut bacteria called AIEC causes to the intestines
- Who participated: Laboratory mice, including special mice bred to develop intestinal inflammation similar to Crohn’s disease, and bacterial cells grown in dishes
- Key finding: Mice that received extra vitamin B12 were protected from AIEC-induced colitis, preventing weight loss and tissue damage. Removing the pduB gene from the bacteria also reduced inflammation and prevented the bacteria from invading intestinal cells.
- What it means for you: This research suggests vitamin B12 supplementation might help protect people with Crohn’s disease from this particular harmful bacteria, though human studies are needed to confirm this works in people the same way it does in mice.
The Research Details
Scientists used laboratory mice to study how a harmful bacteria called AIEC causes intestinal inflammation. They created bacteria with and without a specific gene called pduB to see how important it was for causing disease. They also tested what happened when they gave the mice extra vitamin B12. The researchers measured how sick the mice got by tracking weight loss, tissue damage, and inflammation markers in their intestines.
In addition to mouse studies, the team grew AIEC bacteria in laboratory dishes with intestinal cells to watch how the bacteria invaded the cells. They tested this with and without vitamin B12 present to understand the direct effect of this vitamin on bacterial invasion.
The study used mice that were genetically modified to naturally develop intestinal inflammation, making them a good model for understanding Crohn’s disease in humans.
This research approach is important because it combines multiple methods to understand how bacteria cause disease. By testing in both living mice and in laboratory dishes, the researchers could see both the overall effect on the whole body and the specific way the bacteria interact with intestinal cells. This helps prove that the findings are real and not just coincidence.
The study was published in mBio, a respected scientific journal. The researchers used multiple mouse models and tested their findings in different ways, which strengthens their conclusions. However, this research was done in mice and laboratory conditions, so results may not work exactly the same way in humans. The sample size for mouse studies was not specified in the abstract, which is a limitation for understanding how many animals were tested.
What the Results Show
When scientists removed the pduB gene from AIEC bacteria, the bacteria could no longer invade intestinal cells as effectively. This was surprising because the bacteria could still grow normally and form biofilms, which are sticky communities of bacteria. The key difference was that without this gene, the bacteria couldn’t attach to and invade the intestinal lining.
Mice infected with bacteria lacking the pduB gene developed much less severe colitis compared to mice infected with normal bacteria. These protected mice had less weight loss, less tissue damage, and lower levels of inflammatory chemicals in their intestines.
When researchers gave mice extra vitamin B12, it had a powerful protective effect. Mice receiving vitamin B12 supplementation were protected against colitis even when infected with normal, unmodified AIEC bacteria. They maintained their weight better, had less rectal prolapse (a complication of severe colitis), and showed less tissue damage and inflammation.
The vitamin B12 effect only worked when the bacteria had an intact pdu pathway, meaning the bacteria needed to be able to use vitamin B12 for the vitamin to protect against infection. This shows that vitamin B12 and the pdu gene are directly connected in how the bacteria causes disease.
Mice infected with pduB-deficient bacteria showed reduced expression of pro-inflammatory cytokines, which are chemical signals that trigger inflammation. Specifically, levels of IL-6, IL-1 beta, and TNF-alpha were lower, indicating less inflammatory activity in the intestines. Additionally, the bacteria lacking pduB showed reduced ability to damage the intestinal barrier, which is the protective lining that keeps bacteria out of the bloodstream. Interestingly, mice with higher vitamin B12 levels had better protection against barrier dysfunction, suggesting vitamin B12 strengthens the intestinal defense system.
Previous research had suggested that the pdu operon, a cluster of bacterial genes involved in breaking down certain nutrients, was important for bacterial virulence, or the ability to cause disease. This study confirms that connection and shows specifically how it works. The finding that vitamin B12 can reduce bacterial invasion is novel and suggests a new mechanism by which host nutrition affects bacterial pathogenicity. This adds to growing evidence that micronutrient levels influence how harmful bacteria behave in the gut.
This research was conducted in mice and laboratory dishes, not in humans, so the results may not translate directly to human patients. The study focused on one specific type of harmful bacteria and one specific gene, so results may not apply to other bacteria or other genes. The exact dose of vitamin B12 that would be effective in humans is unknown. Additionally, the study did not examine whether vitamin B12 supplementation might have other effects on the immune system or on beneficial bacteria in the gut. Long-term effects of vitamin B12 supplementation were not studied.
The Bottom Line
Based on this research, vitamin B12 supplementation shows promise as a potential treatment for AIEC-driven colitis, though human clinical trials are needed before recommending it as a standard treatment. The evidence is strong in mouse models but preliminary for human application. People with Crohn’s disease should not change their vitamin B12 intake based on this study alone but should discuss it with their doctor. Current vitamin B12 levels should be checked before considering supplementation, as the optimal dose for protection is unknown.
This research is most relevant to people with Crohn’s disease, particularly those whose disease is driven by AIEC bacteria. Gastroenterologists and inflammatory bowel disease specialists should be aware of these findings. People with inflammatory bowel disease who have low vitamin B12 levels may benefit most from this research. However, people without Crohn’s disease or those whose colitis is caused by other bacteria should not assume these findings apply to them.
In the mouse studies, vitamin B12 supplementation provided protection relatively quickly, preventing disease development when given before infection. However, it is unknown how long it would take to see benefits in humans or whether vitamin B12 would help people who already have active colitis. More research is needed to determine realistic timelines for human patients.
Frequently Asked Questions
Can vitamin B12 supplements help treat Crohn’s disease caused by AIEC bacteria?
Research in mice shows vitamin B12 supplementation protected against AIEC-induced colitis by blocking bacterial invasion and reducing inflammation. However, human clinical trials are needed to confirm whether this works the same way in people with Crohn’s disease.
How does vitamin B12 stop AIEC bacteria from causing intestinal inflammation?
Vitamin B12 blocks the bacteria’s ability to invade intestinal cells by interfering with a bacterial gene called pduB. The bacteria needs this gene and vitamin B12 to invade effectively, so higher vitamin B12 levels prevent the bacteria from attaching and damaging the intestinal lining.
Should people with Crohn’s disease take vitamin B12 supplements based on this research?
This research is promising but was only conducted in mice. People with Crohn’s disease should discuss vitamin B12 supplementation with their gastroenterologist, especially if they have low B12 levels. Do not start supplementation without medical guidance.
What is the pduB gene and why does it matter for Crohn’s disease?
The pduB gene is part of a bacterial pathway that helps AIEC bacteria invade intestinal cells and cause inflammation. When this gene is removed or blocked by vitamin B12, the bacteria cannot invade as effectively, reducing colitis severity in mouse models.
Does this research apply to all types of inflammatory bowel disease?
This research specifically addresses AIEC-driven colitis and Crohn’s disease. Results may not apply to ulcerative colitis, other forms of IBD, or colitis caused by different bacteria. Individual disease causes should be confirmed before applying these findings.
Want to Apply This Research?
- Users with Crohn’s disease could track their vitamin B12 levels monthly through blood tests and correlate this with symptom severity scores, recording abdominal pain, bowel movement frequency, and energy levels to identify personal patterns.
- Users could set reminders to take vitamin B12 supplements at the same time daily and log their intake in the app, while simultaneously tracking gastrointestinal symptoms to monitor whether supplementation correlates with symptom improvement.
- Establish a baseline of current vitamin B12 levels and symptom severity, then monitor changes every 4 to 8 weeks after starting supplementation, tracking both lab values and symptom scores to identify whether vitamin B12 affects individual disease activity.
This research was conducted in mice and laboratory settings. Results have not been tested in humans and may not translate directly to human patients. Vitamin B12 supplementation should not be started or stopped without consulting a healthcare provider, particularly for people with Crohn’s disease or other inflammatory bowel conditions. This article is for educational purposes and should not replace professional medical advice. Always discuss new treatments with your gastroenterologist or physician before making changes to your health regimen.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.